The Therapeutic Potential of Spirooxindoles in Cancer: A Focus on p53–MDM2 Modulation
The p53, often referred to as the “guardian of the genome”, is a well-established tumor-suppressor protein that plays a critical role in regulating the cell cycle, DNA repair, differentiation, and apoptosis, with its activity primarily modulated by the MDM2 protein (murine double minute 2, also know...
Saved in:
| Main Authors: | Adel S. Girgis, Yujun Zhao, Angel Nkosi, Nasser S. M. Ismail, Mohamed S. Bekheit, Dalia R. Aboshouk, Marian N. Aziz, M. Adel Youssef, Siva S. Panda |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-02-01
|
| Series: | Pharmaceuticals |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1424-8247/18/2/274 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Strategies for p53 Activation and Targeted Inhibitors of the p53-Mdm2/MdmX Interaction
by: Ye Huang, et al.
Published: (2025-04-01) -
Mechanistic Role of the Mdm2/MdmX Lid Domain in Regulating Their Interactions with p53
by: Qiuyin Wei, et al.
Published: (2025-04-01) -
Exploring the heterodimer MDM2/MDM4 interaction region uncovers high-affinity peptides for therapeutic p53-reactivation
by: Marika Attili, et al.
Published: (2025-05-01) -
Small-molecule MMRi36 induces apoptosis in p53-mutant lymphomas by targeting MDM2/MDM4/XIAP for degradation
by: Rati Lama, et al.
Published: (2024-12-01) -
New spirooxindole-thiazolidine derivatives as antiseizure agents: Biological evaluation and computational studies
by: Leila Emami, et al.
Published: (2025-05-01)